title: Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort Study.
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Song
authors.affiliation: University of Toronto, Toronto, ON, Canada.
authors.forename: W
authors.initials: W
authors.lastname: Chen
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co. Ltd. Shanghai Branch, Shanghai, China.
authors.forename: W
authors.initials: W
authors.lastname: Liu
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co. Ltd. Shanghai Branch, Shanghai, China.
authors.forename: K
authors.initials: K
authors.lastname: Wang
authors.affiliation: VitalStrategic Research Institute, Shanghai, China.
authors.forename: X
authors.initials: X
authors.lastname: Li
authors.affiliation: Eli Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
authors.forename: K
authors.initials: K
authors.lastname: Wang
authors.affiliation: Eli Lilly Canada, Toronto, ON, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Papadimitropoulos
authors.affiliation: Eli Lilly Australia Pty Ltd,, West Ryde, Australia.
authors.forename: W
authors.initials: W
authors.lastname: Montgomery